BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 31108880)

  • 21. A collagen IV-derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling.
    Mirando AC; Shen J; Silva RLE; Chu Z; Sass NC; Lorenc VE; Green JJ; Campochiaro PA; Popel AS; Pandey NB
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30668550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival.
    Yuan HT; Venkatesha S; Chan B; Deutsch U; Mammoto T; Sukhatme VP; Woolf AS; Karumanchi SA
    FASEB J; 2007 Oct; 21(12):3171-83. PubMed ID: 17504972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A designed angiopoietin-2 variant, pentameric COMP-Ang2, strongly activates Tie2 receptor and stimulates angiogenesis.
    Kim HZ; Jung K; Kim HM; Cheng Y; Koh GY
    Biochim Biophys Acta; 2009 May; 1793(5):772-80. PubMed ID: 19339208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of the receptor tyrosine kinases Tie1 and Tie2 in mediating the effects of angiopoietin-1 on endothelial permeability and apoptosis.
    Milner CS; Hansen TM; Singh H; Brindle NP
    Microvasc Res; 2009 Mar; 77(2):187-91. PubMed ID: 18848573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels.
    Falcón BL; Hashizume H; Koumoutsakos P; Chou J; Bready JV; Coxon A; Oliner JD; McDonald DM
    Am J Pathol; 2009 Nov; 175(5):2159-70. PubMed ID: 19815705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis for angiopoietin-1-mediated signaling initiation.
    Yu X; Seegar TC; Dalton AC; Tzvetkova-Robev D; Goldgur Y; Rajashankar KR; Nikolov DB; Barton WA
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7205-10. PubMed ID: 23592718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer.
    Hata K; Udagawa J; Fujiwaki R; Nakayama K; Otani H; Miyazaki K
    Oncology; 2002; 62(4):340-8. PubMed ID: 12138242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts.
    Saharinen P; Eklund L; Miettinen J; Wirkkala R; Anisimov A; Winderlich M; Nottebaum A; Vestweber D; Deutsch U; Koh GY; Olsen BR; Alitalo K
    Nat Cell Biol; 2008 May; 10(5):527-37. PubMed ID: 18425119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems.
    Eklund L; Kangas J; Saharinen P
    Clin Sci (Lond); 2017 Jan; 131(1):87-103. PubMed ID: 27941161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis.
    Fukuhara S; Sako K; Noda K; Zhang J; Minami M; Mochizuki N
    Histol Histopathol; 2010 Mar; 25(3):387-96. PubMed ID: 20054809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced expression of angiopoietin-2 and the Tie2 receptor but not angiopoietin-1 or the Tie1 receptor in a rat model of myocardial infarction.
    Shyu KG; Liang YJ; Chang H; Wang BW; Leu JG; Kuan P
    J Biomed Sci; 2004; 11(2):163-71. PubMed ID: 14966366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth.
    Hawighorst T; Skobe M; Streit M; Hong YK; Velasco P; Brown LF; Riccardi L; Lange-Asschenfeldt B; Detmar M
    Am J Pathol; 2002 Apr; 160(4):1381-92. PubMed ID: 11943723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiopoietin-2/Tie2 signaling involved in TNF-α induced peritoneal angiogenesis.
    Yuan J; Fang W; Lin A; Ni Z; Qian J
    Int J Artif Organs; 2012 Sep; 35(9):655-62. PubMed ID: 23065888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands.
    Seegar TC; Eller B; Tzvetkova-Robev D; Kolev MV; Henderson SC; Nikolov DB; Barton WA
    Mol Cell; 2010 Mar; 37(5):643-55. PubMed ID: 20227369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of tie2 expression by angiopoietin--potential feedback system.
    Hashimoto T; Wu Y; Boudreau N; Li J; Matsumoto M; Young W
    Endothelium; 2004; 11(3-4):207-10. PubMed ID: 15370298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of Human Neutrophil Extracellular Traps Contributes to Angiopoietin-Mediated In Vitro Proinflammatory and Proangiogenic Activities.
    Lavoie SS; Dumas E; Vulesevic B; Neagoe PE; White M; Sirois MG
    J Immunol; 2018 Jun; 200(11):3801-3813. PubMed ID: 29686052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiopoietin 2 signal complexity in cardiovascular disease and cancer.
    Nicolini G; Forini F; Kusmic C; Iervasi G; Balzan S
    Life Sci; 2019 Dec; 239():117080. PubMed ID: 31756341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells.
    Otani A; Takagi H; Oh H; Koyama S; Honda Y
    Diabetes; 2001 Apr; 50(4):867-75. PubMed ID: 11289054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiopoietin-1, 2 and Tie2 expressions in endometrial adenocarcinoma--the Ang2 dominant balance up-regulates tumor angiogenesis in the presence of VEGF.
    Saito M; Watanabe J; Fujisawa T; Kamata Y; Nishimura Y; Arai T; Miyamoto T; Obokata A; Kuramoto H
    Eur J Gynaecol Oncol; 2006; 27(2):129-34. PubMed ID: 16620053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Angiopoietins and Angiogenic Signaling Pathway Molecules in Chronic Subdural Hematomas.
    Isaji T; Osuka K; Ohmichi Y; Ohmichi M; Naito M; Nakano T; Iwami K; Miyachi S
    J Neurotrauma; 2020 Dec; 37(23):2493-2498. PubMed ID: 32458767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.